Hemodynamic performance of mitroflow aortic pericardial bioprosthesis optimizing management for the small aortic annulus

Thoracic and Cardiovascular Surgeon

Volumn 58, Issue 2, 2010, Pages 69-75

  Jamieson, W R E ^a   Forgie, W R ^b   Hayden, R I ^a   Langlois, Y ^c   Ling, H ^a   Stanford, E A ^a   Roberts, K A ^b   Dolman, W B ^d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d CarboMedics   (United States)

Author keywords

Aortic disease; Cardiomyopathy; Cardiovascular surgery; Coronary bypass surgery; Heart disease; Heart valve surgery

Indexed keywords

ADULT; AGED; AORTA FLOW; AORTA VALVE PROSTHESIS; ARTICLE; BIOPROSTHESIS; CARDIOMYOPATHY; CORONARY ARTERY BYPASS SURGERY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE MASS; HEART VALVE PROSTHESIS; HEART VALVE SURGERY; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VASCULAR RING;

AGED; AGED, 80 AND OVER; ANIMALS; AORTIC VALVE; BIOPROSTHESIS; CANADA; CATTLE; FEMALE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; PERICARDIUM; PROSTHESIS DESIGN; TEXAS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77949995905     PISSN: 01716425     EISSN: 14391902     Source Type: Journal    
DOI: 10.1055/s-0029-1240626     Document Type: Article

References (23)

1. Benhameid O, Jamieson W R. E., Castella M et al. CarboMedics Mitroflow pericardial aortic bioprosthesis performance in patients aged 60 years and older after 15 years. Thorac Cardiovasc Surg 2008 58 1-5
2. Minami K, Boethig D, Mirow N et al. Mitroflow pericardial valve prosthesis in the aortic position: an analysis of long-term outcome and prognostic factors. J Heart Valve Dis 2000 9 112-122
3. Minami K, Zittermann A, Schulte-Eistrup S, Koertke H, Korfer R. Mitroflow Synergy prostheses for aortic valve replacement: 19 years experience with 1516 patients. Ann Thorac Surg 2005 80 1699-1705
4. Pomar J L., Jamieson W R., Pelletier L C., Castella M, Germann E, Brownlee R T. Mitroflow pericardial bioprosthesis experience in aortic valve replacement > or=60 years of age. Ann Thorac Surg 1998 66 S53-S56
5. Pomar J L., Jamieson W R., Pelletier L C., Gerein A N., Castella M, Brownlee R T. Mitroflow pericardial bioprosthesis: clinical performance to ten years. Ann Thorac Surg 1995 60 S305-S310
6. Sjogren J, Gudbjartsson T, Thulin L I. Long-term outcome of the Mitroflow pericardial bioprosthesis in the elderly after aortic valve replacement. J Heart Valve Dis 2006 15 197-202
7. Yankah C A., Schubel J, Buz S, Siniawski H, Hetzer R. Seventeen-year clinical results of 1037 Mitroflow pericardial heart valve prostheses in the aortic position. J Heart Valve Dis 2005 14 172-180
8. Yankah C A., Pasic M, Musci M et al. Mitroflow pericardial aortic valve replacement: durability results up to 21 years. J Thorac Cardiovasc Surg 2008 136 (3) 688-696
9. Garcia-Bengochea J, Sierra J, Gonzalez-Juanatey J R. et al. Left ventricular mass regression after aortic valve replacement with the new Mitroflow 12A pericardial bioprosthesis. J Heart Valve Dis 2006 15 446-452
10. Bleiziffer S, Eichinger W B., Hettich I M., Ruzicka D, Badiu C C., Guenzinger R, Bauernschmitt R, Lange R. Hemodynamic characterization of the Sorin Mitroflow pericardial bioprosthesis at rest and exercise. J Heart Valve Dis 2009 18 95-100
11. PC pericardial bioprosthesis in aortic valve replacement (Abstract). Can J Cardiol 2001 17 (c) 198c
12. Pibarot P, Dumesnil J G. Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve position and its prevention. J Am Coll Cardiol 2000 36 1131-1141
13. Gerosa G, Tarzia V, Rizzoli G, Bottio T. Small aortic annulus: the hydrodynamic performances of 5 commercially available tissue valves. J Thorac Cardiovasc Surg 2006 131 1058-1064
14. Bach D S., Metras J, Doty J R., Yun K L., Dumesnil J G., Kon N D. Freedom from structural valve deterioration among patients aged < or=60 years undergoing Freestyle stentless aortic valve replacement. J Heart Valve Disease 2007 16 (6) 649-655
15. Totaro P, Degno N, Zaidi A, Youhana A, Argano V. Carpentier-Edwards PERIMOUNT Magna bioprosthesis: a stented valve with stentless performance? J Thorac Cardiovasc Surg 2005 130 1668-1674
16. Franzen S F., Nylander E, Olin C L. Aortic valve replacement with pericardial valves in patients with small aortic roots. Clinical results in a consecutive series of patients receiving 19 and 21mm prostheses. Scand Cardiovasc J 2001 35 114-118
17. Ali A, Halstead J C., Cafferty F et al. Early clinical and hemodynamic outcomes after stented and stentless aortic valve replacement: results from a randomized controlled trial. Ann Thorac Surg 2007 83 2162-2168
18. Chambers J B., Rimington H M., Hodson F, Rajani R, Blauth C I. The subcoronary Toronto stentless versus supra-annular Perimount stented replacement aortic valve: early clinical and hemodynamic results of a randomized comparison in 160 patients. J Thorac Cardiovasc Surg 2006 131 878-882
19. Doss M, Martens S, Wood J P. et al. Performance of stentless versus stented aortic valve bioprostheses in the elderly patient: a prospective randomized trial. Eur J Cardiothorac Surg 2003 23 299-304
20. Kunadian B, Vijayalakshmi K, Thornley A R. et al. Meta-analysis of valve hemodynamics and left ventricular mass regression for stentless versus stented aortic valves. Ann Thorac Surg 2007 84 73-78
21. Chambers J, Shah P M. Recommendations for the echocardiographic assessment of replacement heart valves. J Heart Valve Dis 1995 4 9-13
22. Quinones M A., Otto C M., Stoddard M, Waggoner A, Zoghbi W A., Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Recommendations for quantification of Doppler echocardiography: A report from the Doppler quantification task force of the nomenclature and standards committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002 15 167-184
23. Gottdiener J S., Bednarz J, Devereux R et al. American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr 2004 17 1086-1119